株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オピオイド誘発性便秘(OIC):世界の治験レビュー

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 299745
出版日 ページ情報 英文 112 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
オピオイド誘発性便秘(OIC):世界の治験レビュー Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016
出版日: 2016年09月30日 ページ情報: 英文 112 Pages
概要

当レポートでは、オピオイド誘発性便秘(OIC)の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:腫瘍科の治験に対するオピオイド誘発性便秘の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:腫瘍科の治験に対するオピオイド誘発性便秘の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • オピオイド誘発性便秘の治療薬の治験に参加している主要企業

有望薬

最新の治験ニュース

治験プロファイル

  • 主要企業の治験概要
    • Salix Pharmaceuticals Ltd.
    • AstraZeneca PLC
    • Mundipharma International Limited
    • 塩野義製薬
    • Cubist Pharmaceuticals, Inc.
    • Theravance, Inc.
    • Pfizer Inc.
    • Novartis AG
    • Alkermes Plc
    • Alkermes Inc.(休止中)
  • 主要大学・研究機関・病院の治験概要
    • Friedrich-Schiller-Universitat Jena
    • The University of Vermont
    • St. John's Health System
    • VU University Medical Center
    • Shriners Hospitals for Children
    • Kuopio University Hospital
    • British Columbia Cancer Agency
    • UMC Utrecht Holding BV
    • Ullevaal University Hospital

主な臨床プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3817CTIDB

GlobalData's clinical trial report, "Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016" provides an overview of Opioid-Induced Constipation (OIC) clinical trials scenario. This report provides top line data relating to the clinical trials on Opioid-Induced Constipation (OIC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials 28
  • Prominent Drugs 30
  • Clinical Trial Profile Snapshots 31

Appendix 109

  • Abbreviations 109
  • Definitions 109
  • Research Methodology 110
  • Secondary Research 110
  • About GlobalData 111
  • Contact Us 111
  • Disclaimer 111
  • Source 112

List of Tables

  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
  • Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, G7 Countries (%), 2016* 15
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, E7 Countries (%), 2016* 18
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase, 2016* 21
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
  • Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

List of Figures

  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14
  • Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, G7 Countries (%), 2016* 15
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, E7 Countries (%), 2016* 18
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
  • Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
  • GlobalData Methodology 110
Back to Top